Robert I. Wise

1.7k total citations
40 papers, 786 citations indexed

About

Robert I. Wise is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Robert I. Wise has authored 40 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Clinical Biochemistry. Recurrent topics in Robert I. Wise's work include Antimicrobial Resistance in Staphylococcus (14 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antibiotic Resistance in Bacteria (5 papers). Robert I. Wise is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (14 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antibiotic Resistance in Bacteria (5 papers). Robert I. Wise collaborates with scholars based in United Kingdom, United States and Canada. Robert I. Wise's co-authors include Wesley W. Spink, Laura J. V. Piddock, J. M. Andrews, J. M. Andrews, R. Malcolm Brown, Charlotte Witmer, John M. Walker, D. E. Healing, M. Mitchard and A. J. Bint and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Robert I. Wise

38 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert I. Wise United Kingdom 18 256 160 158 142 120 40 786
Burton A. Waisbren United States 18 213 0.8× 484 3.0× 98 0.6× 52 0.4× 84 0.7× 57 962
Richard J. Mangi United States 17 308 1.2× 388 2.4× 123 0.8× 127 0.9× 95 0.8× 33 1.1k
S Ånséhn Sweden 14 177 0.7× 210 1.3× 83 0.5× 103 0.7× 162 1.4× 28 688
Glenn R. Hodges United States 16 175 0.7× 311 1.9× 40 0.3× 110 0.8× 71 0.6× 44 807
D. J. Flournoy United States 18 206 0.8× 273 1.7× 115 0.7× 107 0.8× 93 0.8× 97 866
Louis Weinstein United States 17 165 0.6× 275 1.7× 53 0.3× 78 0.5× 76 0.6× 53 765
J. C. Gould United Kingdom 18 227 0.9× 301 1.9× 67 0.4× 68 0.5× 107 0.9× 57 924
Dieter W. Gump United States 23 169 0.7× 417 2.6× 54 0.3× 118 0.8× 165 1.4× 55 1.3k
Richard B. Prior United States 15 118 0.5× 162 1.0× 100 0.6× 175 1.2× 109 0.9× 52 772
Keiji Kanemitsu Japan 15 231 0.9× 196 1.2× 57 0.4× 113 0.8× 160 1.3× 53 731

Countries citing papers authored by Robert I. Wise

Since Specialization
Citations

This map shows the geographic impact of Robert I. Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Wise more than expected).

Fields of papers citing papers by Robert I. Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Wise. The network helps show where Robert I. Wise may publish in the future.

Co-authorship network of co-authors of Robert I. Wise

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Wise. A scholar is included among the top collaborators of Robert I. Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Wise. Robert I. Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wise, Robert I.. (2003). Introduction: treatment of Gram-positive infections. Journal of Antimicrobial Chemotherapy. 51(90002). 5ii–7. 4 indexed citations
2.
Sarani, Babak, Tiffany Chan, Robert I. Wise, & Stephen R.T. Evans. (2003). Nissen fundoplication has a vagolytic effect on the lower esophageal sphincter. Surgical Endoscopy. 17(8). 1206–1211. 10 indexed citations
3.
Wise, Robert I.. (1998). Science, medicine, and the future. BMJ. 317(7159). 643–644. 153 indexed citations
4.
Fraise, A.P., et al.. (1996). Multidrug-Resistant Streptococcus pneumoniae. Microbial Drug Resistance. 2(4). 431–432. 1 indexed citations
5.
Reeves, D. S., H. A. Holt, Ian Phillips, et al.. (1991). Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres. Journal of Antimicrobial Chemotherapy. 27(4). 469–474. 19 indexed citations
6.
Cooper, Melisa, Ye Jin, J. P. Ashby, J. M. Andrews, & Robert I. Wise. (1990). In-vitro comparison of the postantibiotic effect of vancomycin and teicoplanin. Journal of Antimicrobial Chemotherapy. 26(2). 203–207. 16 indexed citations
7.
Wise, Robert I., et al.. (1989). Personal Reflections on Nosocomial Staphylococcal Infections and the Development of Hospital Surveillance. Clinical Infectious Diseases. 11(6). 1005–1019. 17 indexed citations
8.
Piddock, Laura J. V. & Robert I. Wise. (1987). Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility. Journal of Antimicrobial Chemotherapy. 19(2). 161–170. 43 indexed citations
9.
Wise, Robert I.. (1981). Introduction to the Symposium. Clinical Infectious Diseases. 3(Supplement). S199–S199. 5 indexed citations
10.
Ayliffe, G.A.J., et al.. (1979). A unit for source and protective isolation in a general hospital.. BMJ. 2(6188). 461–465. 20 indexed citations
11.
Gillett, A.P., Robert I. Wise, & A. M. Geddes. (1978). Use of antibiotics. Infection in the compromised host.. BMJ. 2(6133). 335–337. 2 indexed citations
12.
Wise, Robert I., J. M. Andrews, & K. A. Bedford. (1977). The Activity of Four Antimicrobial Agents. Including Three Nitroimidazole Compounds, against <i>Bacteroides</i> sp.. Chemotherapy. 23(1). 19–24. 11 indexed citations
13.
Wise, Robert I., D. S. Reeves, J Symonds, & P. J. Wilkinson. (1976). A Clinical Investigation of Pivmecillinam. Chemotherapy. 22(5). 335–339. 7 indexed citations
14.
Wise, Robert I.. (1976). The Use of Objectives in Curriculum Planning: A Critique of Planning by Objectives. 5(4). 280–280. 5 indexed citations
15.
Wise, Robert I., et al.. (1974). Cephacetrile, a New Cephalosporin, in the Treatment of Urinary Tract Infections. Chemotherapy. 20(3). 177–182. 2 indexed citations
16.
Wise, Robert I., et al.. (1959). The Environmental Distribution of Staphylococcus Aureus in an Operating Suite. Annals of Surgery. 149(1). 30–42. 27 indexed citations
17.
Wise, Robert I., et al.. (1959). A study of staphylococcic colonization of postpartum mothers and newborn infants. American Journal of Obstetrics and Gynecology. 78(6). 1227–1233. 6 indexed citations
18.
Blair, John E., Howard L. Bodily, Valerie Hurst, et al.. (1959). Statement on Availability and Uses of Staphylococcal Phage Typing. American Journal of Public Health and the Nations Health. 49(9). 1184–1188. 4 indexed citations
19.
Blair, John E., Howard L. Bodily, Valerie Hurst, et al.. (1959). Letters to the Editor. American Journal of Public Health and the Nations Health. 49(9). 1192–1193.
20.
Wise, Robert I. & Wesley W. Spink. (1954). The Influence of Antibiotics on the Origin of Small Colonies (G Variants), of Micrococcus Pyogenes var. Aureus1. Journal of Clinical Investigation. 33(12). 1611–1622. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026